{
  "docId": "019de072-bbd9-7497-8511-e9d6798885cf",
  "docSlug": "4834f315ed4fb845204b8a069a89a8ec",
  "documentTitle": "Exscientia | Results Presentation Deck | 33 slides",
  "authorId": "exscientia",
  "authorName": "Exscientia",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-05-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 3,
  "pageCount": 33,
  "prevPage": 2,
  "nextPage": 4,
  "slideType": "kpi_overview",
  "function": "summarize",
  "density": "overcrowded",
  "nDataPoints": 3,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de072-bbd9-7497-8511-e9d6798885cf/3",
  "deckHref": "/decks/019de072-bbd9-7497-8511-e9d6798885cf",
  "deckJsonHref": "/decks/019de072-bbd9-7497-8511-e9d6798885cf.json",
  "deckAnchorHref": "/decks/019de072-bbd9-7497-8511-e9d6798885cf#slide-3",
  "components": [
    {
      "bbox": {
        "h": 0.08,
        "w": 0.4,
        "x": 0.52,
        "y": 0.59
      },
      "kind": "list",
      "text": "'546 top-line data expected in 1H 2022",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1c11c98e-66b2-460e-b266-acc922d9df98",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.4,
        "x": 0.52,
        "y": 0.44
      },
      "kind": "list",
      "text": "'617 CTA submission expected by year-end 2022",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "21210806-cef1-4d6b-9b02-b6554aec2fa2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.4,
        "x": 0.07,
        "y": 0.79
      },
      "kind": "list",
      "text": "Extended BMS collaboration to leverage precision medicine platform",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3e3227d2-cf6c-4e89-956c-3120ae2d0a7c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.4,
        "x": 0.07,
        "y": 0.44
      },
      "kind": "list",
      "text": "Sanofi $5.2 billion collaboration signed; target identification and validation ongoing",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7dad5c39-e54a-4e17-9dc8-36e1710d3c62",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.4,
        "x": 0.07,
        "y": 0.64
      },
      "kind": "list",
      "text": "Data at AACR highlighted patient tissue platform capabilities",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "828f063c-2ac2-4740-81c7-2ff87e1f4ea9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.4,
        "x": 0.52,
        "y": 0.74
      },
      "kind": "list",
      "text": "'546 Phase 1b/2 start in 2H 2022 in high adenosine signature cancers",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "dd77f70b-5386-494e-ac1d-88f06d5bb752",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.26,
        "x": 0.07,
        "y": 0.21
      },
      "kind": "metric",
      "text": "Cash and cash equivalents as of March 31, 2022: $719.8 million",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "004de9e4-00f9-485a-84dc-8d694008e450",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.26,
        "x": 0.67,
        "y": 0.21
      },
      "kind": "metric",
      "text": "1Q 2022 operational cash burn: $10.4 million",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "19ca187d-0328-4e9a-abb1-29404df7217a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.26,
        "x": 0.37,
        "y": 0.21
      },
      "kind": "metric",
      "text": "Cash inflows from Sanofi collaboration in 2Q 2022: $100 million",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ee265f8d-7803-4c54-9e85-5ff9bd87ff02",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.35,
        "x": 0.07,
        "y": 0.07
      },
      "kind": "title",
      "text": "Well-positioned to deliver",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3c494f02-96e9-4eaa-b25e-88159408b04d",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Call to action",
      "slug": "call-to-action",
      "agent": null,
      "layer": "slide",
      "matchId": "6c761f8d-95d4-4409-9873-7ff2039fff67",
      "evidence": "metric/big-number: Cash inflows from Sanofi collaboration in 2Q 2022: $100 million",
      "confidence": 0.5
    },
    {
      "name": "Storytelling: audience calibration",
      "slug": "audience",
      "agent": "storyteller",
      "layer": "slide",
      "matchId": "b78ce2d7-bdf0-471b-b708-f7bd30226e38",
      "evidence": "list/bullet: Sanofi $5.2 billion collaboration signed; target identification and validation ongoing",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 4,
      "from": 1,
      "beatId": "fa0d8cf6-1d7c-41f0-a31a-408cfd4795c8",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Setup",
      "beatSlug": "setup",
      "evidence": "The deck sets up Exscientia's position in AI-driven precision medicine",
      "position": 0,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}